Litcius/Paper detail

Converting primary tumor towards an in situ STING-activating vaccine via a biomimetic nanoplatform against recurrent and metastatic tumors

Xue Yang, Ying Yang, Jiayi Bian, Jiajia Wei, Zheng Wang, Zhanwei Zhou, Zhaoting Li, Minjie Sun

2021Nano Today72 citationsDOI

Topics & Concepts

StingTumor microenvironmentImmunotherapyMedicineCancer immunotherapyVaccinationCancer researchImmune systemCancer vaccineCancerPrimary tumorStimulator of interferon genesImmunologyMetastasisInternal medicineInnate immune systemAerospace engineeringEngineeringinterferon and immune responsesNanoplatforms for cancer theranosticsVirus-based gene therapy research
Converting primary tumor towards an in situ STING-activating vaccine via a biomimetic nanoplatform against recurrent and metastatic tumors | Litcius